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The success of nanoparticle-based cancer therapies ultimately depends on their ability to selectively and
eﬃciently accumulate in regions of disease. Outﬁtting nanoparticles to actively target tumor-speciﬁc
markers has improved speciﬁcity, yet it remains a challenge to amass adequate therapy in a selective
manner. To help address this challenge, we have developed a mechanism of nanoparticle ampliﬁcation
based on stigmergic (environment-modifying) signalling, in which a “Signalling” population of gold
nanorods induces localized unveiling of cryptic collagen epitopes, which are in turn targeted by
“Responding” nanoparticles bearing gelatin-binding ﬁbronectin fragments. We demonstrate that this
two-particle system results in signiﬁcantly increased, selective recruitment of responding particles. Such
ampliﬁcation strategies have the potential to overcome limitations associated with single-particle
targeting by leveraging the capacity of nanoparticles to interact with their environment to create
abundant new binding motifs.Introduction
Nanoparticle delivery strategies for targeting cancer have great
potential for improving cancer therapy by accumulating at sites
of disease while sparing healthy tissues. Advances in active
targeting of tumor receptors have yielded particles which home
to particular cancer-associated markers rather than solely
relying upon passive selectivity derived from physical parame-
ters.1–3 However, such targeting remains restricted by several
factors, including limited receptor availability,4 receptor
heterogeneity amongst tumors, imperfect selectivity due to
normal expression of receptors on healthy cells, and constraintsand Technology, 77 Massachusetts Ave.
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Chemistry 2013on penetration depth such as binding site barriers5 and dense,
brous matrix. Many natural processes such as the immune
response and downstream signalling from growth factors
overcome similar hurdles through amplication schemes at the
molecular and cellular level. Because of their versatility, nano-
particles can be engineered to participate in signal amplica-
tion as a means of overcoming biological limitations on
targeting.
Nanoparticle amplication has been used to great eﬀect for
ultra-sensitive cancer diagnostics, such as using gold nano-
sphere-mounted DNA bar codes for PCR-based detection of
scarce proteins.6 Our group has recently begun exploring
the possibility of harnessing amplication in the tumor
setting through modalities including (1) dynamic nanoparticle-
mediated upregulation of targetable surface receptors via the
cellular machinery7 and (2) integration of nanoparticles into the
self-amplifying coagulation cascade to generate targetable
microclots.8 However, the possibility of exploiting the tumor
environment as a substrate for amplied targeting has not yet
been explored.
We hypothesize that amplication of nanoparticle binding
can be mediated by selective disruption of tumor-associated
extracellular matrix (ECM), thus incorporating a manner of
“stigmergic” coordination, in which insoluble environmental
cues le by a signalling population recruit an overwhelming
responding population. ECM molecules adopt intricate super-
structures that display rigid, repeating epitopes, and physical
interruption of these structures can alter mechanosensitive
binding sites. For instance, tensile disruption of bronectin
bers has been shown to functionally eliminate bindingJ. Mater. Chem. B, 2013, 1, 5235–5240 | 5235
Fig. 1 Schematic of nanoparticle ampliﬁcation via photothermal denaturation
of collagen. Near-infrared irradiation induces surface plasmon resonance in gold
nanorods, locally heating collagen and exposing cryptic epitopes. Fibronectin
fragment-conjugated nanoworms recognize denatured collagen but not intact
ﬁbrils, allowing them to ‘Respond’ to gold nanorod activity. This process produces
speciﬁc, ampliﬁed accumulation of responding nanoparticles at sites of gold
nanorod localization.
Fig. 2 Nanoparticle components comprising the signalling and responding
modules. (A) Absorbance spectrum of gold nanorods. Inset: TEM of gold nano-
rods, scale bar: 40 nm. (B) Left: visible-light photograph of gold nanorod solution
(left) and saline solution (right). Right: thermographic image contrasting heating
response of gold nanorods (light) and saline solution (right) to near-infrared laser
(l ¼ 808 nm). (C) TEM images of intact collagen ﬁbers and collagen denatured by
heating (inset). (D) The gelatin-binding proteolytic fragment of ﬁbronectin (FnF,
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View Article Onlineepitopes recognized by pathogenic bacteria.9 Simultaneously,
formerly cryptic motifs can emerge,10 serving as plentiful yet
disease-specic binding sites.
In this work, we have constructed an amplication system
around the denaturation of collagen, in which the signalling
population consists of gold nanorods that accumulate near
collagen and, as a result of near-infrared laser-induced surface
plasmon resonance, denature collagen brils. These brils are
then targeted by a responding population of bronectin frag-
ment-functionalized iron oxide nanoparticles that actively
target denatured but not intact collagen (Fig. 1).red) is used as a targeting domain, conjugated to a dextran-coated iron oxide
nanoworm (NW) bearing near-infrared ﬂuorescent tracking dye (green). Inset:
TEM of iron oxide NW. Scale bar: 20 nm. (E) Size distributions of nanoworms
conjugated to dye only (blue) or dye and FnF (red), as measured by dynamic light
scattering.Results
The tumor milieu and associated stroma are rich in extracel-
lular matrix molecules, which present an abundant source of
potential binding sites for nanoparticle targeting. Amongst the
myriad of ECM components, Type I collagen is ubiquitous and
implicated in promoting malignancy.11 Moreover, as a frequent
target of structural remodeling, collagen naturally possesses the
malleability to permit signal propagation through a change in
physical state. The denaturation threshold of collagen's quar-
ternary structure lies near physiologic temperature,12 suggest-
ing that denaturation of the native triple helix into partially
unwound congurations via non-ablative supraphysiologic
heating may be a feasible mechanism for generating an
amplied physical signal. The folded and denatured states
present contrasting epitopes which permit unique recognition
of the denatured state; for instance, glycine residues are only
revealed in denatured collagen,10 altering the spatial congu-
ration of residues involved in the ionic interactions thought to
mediate bronectin binding.13,14
To construct a collagen-centric amplication system out of
nanoparticles, we developed a signalling mechanism to induce
local hyperthemia and paired this with a secondary signal-
responsive mechanism that would recognize and accumulate at
binding sites revealed by hyperthermia. We selected PEG-pro-
tected gold nanorods as the signalling component, as they can
heat the local environment through near infrared laser-medi-
ated surface plasmon resonance (Fig. 2A and B). PEGylated gold5236 | J. Mater. Chem. B, 2013, 1, 5235–5240nanorods are amenable to use as cancer therapy because of
their small size, favorable circulation half-life of 17 hours,15
and peak excitation wavelength in the rst near-infrared optical
window (Fig. 2A), a range of wavelengths to which skin and
other tissues are more permissive compared to visible or
ultraviolet light.16
Heating collagen disrupts its tri-helical tertiary structure
(Fig. 2C), revealing cryptic epitopes which represent a tumor-
specic target for therapeutic secondary particles. We used a
45 kDa gelatin-binding bronectin fragment (FnF) to target
denatured collagen (Fig. 2D). To establish the minimal
temperature that enables FnF recognition of the cryptic
collagen I epitopes, we measured the temperature-dependent
binding of unconjugated FnF to collagen-coated wells in a 96-
well plate, compared to the binding of albumin control (Fig. 3A).
Binding of FnF and albumin to uncoated plates was minimal
and not temperature-dependent.
Since practical applications would incorporate FnF as a
targeting moiety rather than a standalone polypeptide, we
generated representative responding nanoparticles that
embody the typical size and multivalency of a potential ther-
apeutic or diagnostic nanoparticle. For the backbone of these
particles, we used aminated dextran-coated iron oxideThis journal is ª The Royal Society of Chemistry 2013
Fig. 3 Characterization of the responding nanoparticles. (A) Relative binding of ﬂuorescently labeled ﬁbronectin fragment (FnF) or bovine serum albumin (Alb) to
wells coated in collagen (Coll) or left uncoated, as a function of the temperature to which the collagen-coated or uncoated wells were subjected prior to protein
addition. Temperature was regulated by water bath. Asterisks in (A) and (B) indicate statistical signiﬁcance by two-way ANOVA with Bonferroni post test across
temperatures, comparing against 37 C (*: p < 0.05, **: p < 0.01, ***: p < 0.001). Error bars indicate standard deviation. (B) Relative temperature-dependent binding of
FnF-conjugated nanoworms (FnF-NW) and albumin-conjugated nanoworms (Alb-NW) to collagen- or albumin-coated wells. Temperature was regulated by water bath.
Inset: representative scans of ﬂuorescent FnF-NWs (green) bound to collagen incubated at room temperature or 49 C. Scale bar: 2 mm. (C) Normalized binding curves
contrasting relative binding to denatured collagen as a function of FnF or FnF-NW concentration. (D) Normalized temperature-dependent binding curves, combined
from (A) and (B), contrasting the relative binding of free FnF and FnF-NW to collagen heated to diﬀerent temperatures. Asterisk indicates p < 0.05 by two-way ANOVA
with Bonferroni post test (FnF-NWs vs. free FnF). Curve ﬁt is a variable-slope sigmoidal dose response.
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View Article Onlinenanoworms (NWs), which are elongated particles consisting of
linear chains of approximately spherical cores.17 The NW
backbone was selected because of its paramagnetic properties,
demonstrated to be useful for MRI diagnostic applications.
NWs with amine-conjugated near-infrared tracking uo-
rophores (VivoTag-S750) were functionalized with either FnF
or albumin. Using dynamic light scattering, we determined
that NWs with covalently linked FnF (FnF-NWs) had an
average hydrodynamic diameter of 52.2 nm, versus 36.5 nm for
NWs with near-infrared dye only, a size increase consistent
with the addition of 45 kDa polypeptides over the surface of
the nanoparticles (Fig. 2E).18
The temperature-dependent binding of the functionalized
nanoworms was examined (in an analogous setup to the free
protein experiment) to conrm their binding response to
idealized collagen heating (Fig. 3B; see inset for representative
imaging). To determine the eﬀects of multivalency, we
measured concentration-dependent binding of free FnF versus
FnF-NW on a molar basis of protein or NW cores (Fig. 3C).
These curves demonstrated a leward shi along the concen-
tration axis, indicating higher denatured collagen binding
aﬃnity for the FnF-NW formulation relative to free FnF.
Furthermore, when the FnF and FnF-NW temperature-depen-
dent binding curves from Fig. 3A and B are normalized for
specic binding and compared head-to-head, there is an oﬀset
between the binding curves, with half-maximal bindingThis journal is ª The Royal Society of Chemistry 2013temperatures of 43.4 C for free FnF and 41.7 C for FnF-NW
(Fig. 3D).
Combining the signalling and responding components,
we characterized the behavior of the full two-nanoparticle
system. We introduced gold nanorods over collagen or
control substrate (bovine serum albumin) in a 96-well plate
and irradiated the wells to 45  1 C at steady-state, with
nanorod concentrations and laser intensities based on
experimental kinetic heating curves including those dis-
played in Fig. 4A. The laser power density required to heat the
nanorods to the target temperature under these conditions
was <0.5 W cm2. Aer removal of the nanorods, the wells
were then incubated with nanoworms conjugated to FnF or
control albumin. Under these conditions, we observed a
statistically signicant six-fold increase in binding of the
FnF-NWs to collagen over baseline unheated controls (p <
0.001), whereas combinations with control substrate or
control targeting moieties showed no such increase (Fig. 4B).
To demonstrate basic spatial specicity of the two-particle
system, we added gold nanorods to specic wells of a
collagen-coated 96-well plate in a pattern (Fig. 4C, inset;
nanorod-containing wells denoted by red ll) and irradiated
all wells equally with the near-infrared laser. Responding
nanoparticles only accumulated appreciably in wells with
nanorods, conrming that there was minimal heating inde-
pendent of the nanorods (Fig. 4C).J. Mater. Chem. B, 2013, 1, 5235–5240 | 5237
Fig. 4 Ampliﬁcation of nanoparticle accumulation through stigmergy. (A)
Representative heating kinetics of gold nanorods at diﬀerent concentrations
(black circles: 0.0, green squares: 12.5, blue triangles: 17.7, purple triangles: 33.9,
red diamonds: 70.6, all in mgmL1), under constant irradiation by an 808 nm laser
(120 mW cm2). (B) Conjugated nanoworm binding to collagen or albumin
substrates exposed to either unirradiated nanorods (left) or nanorods irradiated
by near-infrared (NIR) laser to 45 C (right). ***indicates p < 0.001 by two-way
ANOVA with Bonferroni post test for irradiated vs. unirradiated. (C) Collagen-
coated 96-well plate with nanoworms added only to wells in a pattern based on
the “MIT” logo. The entire plate was irradiated by near-infrared laser as in (B), and
all wells in the image were subsequently incubated with FnF-NWs.
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View Article OnlineDiscussion
Coordinating amplication via ECM modication oﬀers a
mechanism for specic accumulation of targeted nanoparticles
by refashioning the environment to display epitopes that are
not normally accessible under physiologic conditions. In
comparison with other methods of mediating nanoparticle
binding, this approach does not require diﬀerential expression
or upregulation of a receptor, nor homogeneous receptor
expression. We measured a 7.2 increase in binding with free
FnF to water bath-heated collagen as well as a 6.8 increase in
binding of FnF-NW to gold nanorod-heated collagen aer
normalizing to stringently control for any targeting conferred by
the fraction of collagen which is unwound or accessible at 37 C.
These increases were specic to FnF and FnF-NWs, and neither
control substrates nor untargeted particles contributed to5238 | J. Mater. Chem. B, 2013, 1, 5235–5240binding (Fig. 3A and B). Consequently, non-specic accumula-
tion in areas exposed only to the near-infrared laser or only to
gold nanorods is minimal (Fig. 4B). The fold binding increase
we observed corresponds with the magnitude of responses
reported in previous investigations of peptide-targeted NWs.19
The consistency in binding enhancement across our
diﬀerent experimental congurations speaks to the modularity
of the targeting moiety and its potential for use with a thera-
peutic responding particle rather than a diagnostic one such as
the iron oxide NWs. The changes in collagen structure induced
by either water bath or gold nanorod heating were not rapidly
reversed when hyperthermia was withdrawn, as the responding
particles in these experiments were only added aer plates were
cooled to 4 C, suggesting that the system is forgiving towards
temporal spacing between the two particle populations. This
contrasts with amplication schemes which rely upon direct
particle-to-particle interaction or catalysis, or the transient
accumulation of soluble signalling intermediates. These nd-
ings corroborate evidence in the literature that the collagen I
denaturation–renaturation process displays signicant hyster-
esis, with much slower renaturation, and that reformed
collagen brils have signicant representation of homotrimers
and partially unwound gelatin.12
The practicality of harnessing the instability of collagen
brils was borne out in our temperature-dependent binding
studies, wherein the binding of free FnF showed half-maximal
binding at 43.4 C, while the FnF-NWs reached half-maximal
binding at 41.7 C. Importantly, these target temperatures lie
within the bounds of mild hyperthermia previously described
for non-ablative cancer therapy to enhance drug uptake.20 The
lower temperature threshold for functionalized NWs versus free
peptide (Fig. 3D) is favorable because it brings the temperatures
required for optimal binding down from temperatures that
could induce counterproductive coagulation. The basis of the
binding at lower temperatures – and hence, with fewer binding
sites – may be multivalent presentation of the FnF, which is
supported by the lower concentration threshold for binding
seen in FnF-NWs versus free FnF (Fig. 3C). Therefore, the use of
nanoparticles as the responding element confers improved
binding characteristics on account of multivalency.
On the signalling side of the amplication scheme, the need
for nanoparticle “antennae” for the outwardly straightforward
task of inducing hyperthermia is for the purposes of conning
heat-mediated changes to a local site of disease, promoting
specicity and safety. Because laser-induced heating only occurs
where the nanorods have accumulated, as demonstrated in
Fig. 4C, and because accumulated heat generally dissipates
poorly from tumors,21 employing temperatures in the range of
40–45 C in the tumor represents reduced risk of hyperthermic
damage to surrounding tissue compared to local thermoablative
tumor therapy.22,23 The choice of local heating rather than whole-
body hyperthermia, modeled here by the water bath, helps to
avoid the side-eﬀects or mortality associated with elevating the
entire body over 42.5 C,21 and the 122–376mW cm2 laser power
intensity used in our experiments (measurements not shown) is
below or comparable to the conservative 330 mW cm2 limit on
occupational exposures to 808 nm light up to 3  104 s.24This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineGold nanorod-mediated photothermal denaturation of ECM
components as a mechanism of indirect signal amplication
also presents potential benets in future translation of such a
system into animals. The TEM images of heat-induced
unwinding of collagen (Fig. 2C) suggest the possibility of
modifying the ECM in a manner which may promote greater
transport through the barrier-like tumor stroma, which has
been a strategy pursued previously through enzymatic25,26 and
receptor-based27 means. In addition, the application of hyper-
thermia itself induces changes outside of ECM denaturation,
and we predict that recruitment of the responding particles
would be further enhanced in vivo due to transient vascular
changes associated with tumor hyperthermia.28Conclusions
We have therefore designed and demonstrated a two-nano-
particle system in which a signalling population enables the
amplied recruitment of a secondary responding species
through modication of ECM collagen I. Each nanoparticle is
individually simple but specialized for its role: the gold nano-
rods can eﬀect local hyperthermia, and the multivalent bro-
nectin fragment nanoworms show signicant binding
specicity for collagen denatured at temperatures just above a
high fever. Splitting these functions into separate particles
presents the opportunity for intermediate amplication, as we
have shown in vitro. We believe that the assembly of nano-
particles into cooperative systems that convert ubiquitous ECM
components into unique binding sites can build upon tradi-
tional active targeting strategies to enhance tumor-specic
nanoparticle accumulation.Materials and methods
Preparation of gold nanorods
Bare gold nanorods (30-10-808, Nanopartz, Loveland, CO), 10
nm axial diameter  41 nm length, were concentrated via
centrifugation at 14 000g. Pellets were consolidated and reacted
with 250 mM 5 kDa PEG-thiol (Laysan Bio, Inc., Arab, AL), and
excess PEG and surfactant were removed by overnight dia-
lyzation in 5 kDa Spectra/Por cellulose ester membrane (Spec-
trum Labs, Rancho Dominguez, CA) against ddH2O. Finally,
PEGylated nanorods were concentrated to 100 OD (1 cm path,
808 nm, equivalent to 3.6 mgmL1 and 5.9 1013 nanorods per
mL) using a 100 kDa Amicon Ultra spin lter column at 4000g
(EMD Millipore, Billerica, MA).Fluorophore-conjugated proteins
45 kDa bronectin proteolytic fragment (F0162, Sigma-Aldrich,
St. Louis, MO) or bovine serum albumin (Sigma-Aldrich), dis-
solved in 25 mM HEPES salt buﬀer, pH 7.5, was mixed with a
2 : 1 molar ratio of VivoTag-S750 (Perkin-Elmer, Waltham, MA)
and allowed to shake for 2 hours at room temperature. Labeled
product was dialyzed against 1 phosphate-buﬀered saline
(PBS), pH 7.1, to remove excess dye.This journal is ª The Royal Society of Chemistry 2013Fluorophore-labeled iron oxide nanoworms
Iron oxide nanoworms (NWs) were synthesized as previously
reported17 and aminated using 20% vol/vol ammonium
hydroxide, with excess ammonia removed by dialysis. Nano-
particles were labeled with near-infrared uorophore (VivoTag-
S750) at a 10 : 1 molar ratio of dye : NW in 1 PBS for 2 hours at
room temperature. Excess uorophore was removed by centri-
fugation in a 100 kDa spin lter column at 4000g.Protein-conjugated nanoworms
Following uorophore labeling, remaining free amines on NWs
were activated using a homobifunctional NHS-PEO5-NHS linker
(Thermo Scientic, Waltham, MA) at a 500 : 1 linker : NW ratio.
Aer shaking at room temperature for 30 minutes, excess linker
was removed using 100 kDa spin lter. NWs were then added to
bronectin fragment or albumin solutions for a nal 7 : 1
peptide : NW molar ratio. Reaction was allowed to proceed
overnight at room temperature while shaking. Excess peptide
was removed by 100 kDa spin lter and resuspended in 1 PBS
to 1 mg mL1 for use in experiments. Hydrodynamic diameter
was determined using dynamic light scattering (Zetasizer Nano
ZS90, Malvern, Worcestershire, UK).Collagen-coated plates
Black (3603, Corning, Corning, NY) or white (3610, Corning)
clear-bottom 96-well plates were lled with 100 mL per well of
32 mg mL1 sterile rat collagen or bovine serum albumin diluted
in carbonate-bicarbonate buﬀer (pH 9.6), then incubated over-
night at 4 C. Uncoated wells were lled with buﬀer only.Water bath experiments
Collagen/albumin-coated black clear-bottom plates were sealed
by adhesive acetate plate sealers and then immersed for 10 min
in a stirred water bath of appropriate feedback-regulated
temperature. Plates were then cooled for 10 min at 4 C to
simulate the partial refolding occurring when heat is with-
drawn.12 Collagen, bovine serum albumin solution, or buﬀer
was aspirated and replaced with either protein–uorophore
conjugate (40 mL at 3 mg mL1 or 10 mg mL1 by protein mass,
uniform within each experiment) or NW–uorophore–protein
conjugate (40 mL at 25 mg mL1 of core NWmass,Mw  115 kDa
per core). Aer two sequential PBS rinses, plates were read using
a LI-COR Odyssey Imaging System at l ¼ 800 nm (LI-COR
Biosciences, Lincoln, NE), and signal was integrated per well
(n ¼ 3 per condition) using built-in soware. Resulting
temperature-dependent binding curves were t to a generic
variable-slope sigmoidal curve of the form.
B ¼ Bmin þ Bmax  Bmin
1þ 10SðT1=2TÞ
;
where B ¼ binding magnitude, S is the slope, T ¼ temperature,
T1/2 is the temperature at half-maximal binding, and Bmax and
Bmin are xed to 1 and 0, respectively, to account for normali-
zation and baselines.J. Mater. Chem. B, 2013, 1, 5235–5240 | 5239
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View Article OnlineNanorod heating experiments
0.5 mL of 100 OD (3.5 mgmL1) PEGylated nanorods were added
per well in collagen-coated white plates, diluted into the
collagen solution. Wells receiving laser treatment were irradi-
ated with 808 nm laser for 10 min at 300 mW cm2; power
levels were conrmed by handheld laser power meter (Edmund
Optics, Barrington, NJ). The entire plate was cooled for 10 min
at 4 C prior to aspiration of the collagen solution and
replacement with NW–uorophore–protein conjugate (40 mL at
25 mg mL1). The remainder of the procedure was identical to
the water bath experiments above. n ¼ 4 per condition.TEM imaging
Gold nanorods or collagen solutions were dispensed onto TEM
grids. Staining and imaging was performed by the W. M. Keck
Microscopy Facility at the Whitehead Institute.Acknowledgements
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